GNTA
Genenta Science S.p.A. American Depositary Shares (GNTA)
$61
About Genenta Science S.p.A. American Depositary Shares (GNTA)
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Details
Daily high
$5.70
Daily low
$4.65
Price at open
$5.15
52 Week High
$5.87
52 Week Low
$2.20
Market cap
102.2M
Dividend yield
0.00%
Volume
28,438
Avg. volume
11,933
P/E ratio
-8.12
Genenta Science S.p.A. American Depositary Shares News
Details
Daily high
$5.70
Daily low
$4.65
Price at open
$5.15
52 Week High
$5.87
52 Week Low
$2.20
Market cap
102.2M
Dividend yield
0.00%
Volume
28,438
Avg. volume
11,933
P/E ratio
-8.12